首頁 > 市場調查報告書 > 醫療設備

顱內動脈瘤市場規模、佔有率和成長分析（按產品類型、類型、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1898588

顱內動脈瘤市場規模、佔有率和成長分析（按產品類型、類型、最終用戶和地區分類）—2026-2033年產業預測

Intracranial Aneurysm Market Size, Share, and Growth Analysis, By Product Type (Aneurysm Therapeutic Devices, Embolization Devices), By Type (Saccular aneurysm, Fusiform aneurysm), By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球顱內動脈瘤市場規模預計在 2024 年達到 14.2 億美元，從 2025 年的 15.5 億美元成長到 2033 年的 30.8 億美元，在預測期（2026-2033 年）內複合年成長率為 9%。

受人口老化、早期診斷和介入意識增強以及醫療技術快速發展的推動，全球顱內動脈瘤市場持續穩定成長。已開發市場和新興市場醫療費用支出的增加，提高了患者獲得必要診斷和治療服務的可近性。微創血管內治療技術的創新，例如栓塞術和血流晶粒，因其創傷小、住院時間短、康復快而備受青睞。此外，先進的影像技術提高了檢測精度和治療方案製定的準確性。然而，高昂的治療費用和複雜手術帶來的風險等挑戰，可能會阻礙患者和醫療機構對這些技術的接受度。因此，降低治療成本並提高治療的安全性和有效性，對於市場發展至關重要。

全球顱內動脈瘤市場促進因素

全球顱內動脈瘤市場的成長主要得益於醫療技術的進步。微創血管內治療、先進的影像技術以及尖端醫療設備的研發等創新舉措，都有助於改善治療效果。這些技術進步不僅提升了治療效果，也減輕了患者的負擔，縮短了復原時間。隨著醫療專業人員不斷採用這些先進治療方法，市場呈現上升趨勢，這反映了在改善腦動脈瘤患者照護和最佳化治療方案方面所做的持續努力。

限制全球顱內動脈瘤市場的因素

全球顱內動脈瘤市場面臨嚴峻挑戰，治療費用高昂，尤其是需要特殊醫療設備和外科手術的複雜病例。不斷上漲的費用會限制患者獲得必要的治療，特別是經濟條件有限的患者。此外，醫療系統面臨的經濟負擔會阻礙整體服務提供，並導致治療機會不均等。這種經濟障礙凸顯了開發創新解決方案的必要性，這些方案旨在提高成本效益，並使顱內動脈瘤患者更容易獲得有效治療。

全球顱內動脈瘤市場趨勢

全球顱內動脈瘤市場正迅速向微創手術轉型，尤其是血管內介入技術，例如栓塞術和血流晶粒術。這一趨勢反映了整個醫療領域以患者為中心的更廣泛趨勢，強調減少創傷和加快康復速度。隨著這些技術的日益精進，它們相比傳統開放性手術具有顯著優勢，包括創傷更小、患者預後更佳。先進影像和導管技術的應用進一步加速了這一趨勢，促進了這些手術的廣泛普及。這種不斷變化的格局表明，神經外科領域對兼顧療效和患者舒適度的創新治療方法的需求日益成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic plc（Ireland）
Stryker Corporation（United States）
MicroPort Scientific Corporation（China）
Johnson & Johnson Services, Inc.（United States）
MicroVention Inc.（United States）
B. Braun Melsungen AG（Germany）
Integra LifeSciences（United States）
RAUMEDIC AG（Germany）
Terumo Corporation（Japan）
Delta Surgical（United Kingdom）
MicroVention Terumo（United States）
Penumbra, Inc.（United States）
Balt USA（United States）
Phenox GmbH（Germany）
InspireMD, Inc.（Israel）
Kaneka Medix Corporation（Japan）
Evasc Neurovascular Enterprises ULC（Canada）

結論與建議

簡介目錄

Product Code: SQMIG35A2427

Global Intracranial Aneurysm Market size was valued at USD 1.42 Billion in 2024 and is poised to grow from USD 1.55 Billion in 2025 to USD 3.08 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The global market for intracranial aneurysms is witnessing consistent expansion, fueled by an aging demographic, heightened awareness regarding early diagnosis and intervention, and rapid advancements in medical technology. Increased healthcare spending in both developed and emerging markets is enhancing accessibility to essential diagnostic and therapeutic services. Innovations in minimally invasive endovascular techniques, such as coiling and flow diversion, are particularly favored for their reduced invasiveness, shorter hospital stays, and quicker recovery. Additionally, advanced imaging technologies have improved detection accuracy and treatment planning. However, challenges such as the high costs of treatment and the risks associated with complex procedures may hinder patient and provider adoption. Focusing on cost reduction and refining treatment safety and efficacy will be crucial for market progression.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intracranial Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intracranial Aneurysm Market Segments Analysis

Global Intracranial Aneurysm Market is segmented by Product Type, Type, End-User and region. Based on Product Type, the market is segmented into Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices and Access Devices. Based on Type, the market is segmented into Saccular aneurysm, Fusiform aneurysm and Mycotic aneurysm. Based on End-User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intracranial Aneurysm Market

The growth of the global intracranial aneurysm market is significantly propelled by advancements in medical technology. Innovations such as minimally invasive endovascular procedures, enhanced imaging techniques, and the creation of cutting-edge devices contribute to improvements in treatment efficacy. These technological breakthroughs not only result in superior patient outcomes but also minimize discomfort and lead to quicker recovery periods. As healthcare practitioners continue to adopt these advanced modalities, the market is poised for expansion, reflecting the ongoing commitment to improving patient care and optimizing therapeutic approaches for managing intracranial aneurysms.

Restraints in the Global Intracranial Aneurysm Market

The Global Intracranial Aneurysm market faces significant challenges due to the high costs associated with treatment, particularly for complex cases that necessitate specialized medical devices or surgical procedures. These elevated expenses can restrict patient access to essential care, particularly among those with limited financial resources. Additionally, the financial burden imposed on healthcare systems can hinder the overall provision of services, potentially resulting in inequalities in treatment availability. This economic barrier underscores the need for innovative solutions that can improve affordability and facilitate broader access to effective interventions for patients suffering from intracranial aneurysms.

Market Trends of the Global Intracranial Aneurysm Market

The Global Intracranial Aneurysm market is increasingly shifting towards minimally invasive procedures, particularly endovascular techniques like coiling and flow diversion. This trend reflects a broader healthcare emphasis on patient-centered care, emphasizing reduced invasiveness and shorter recovery periods. As these techniques become more refined, they offer significant advantages over traditional open surgeries, including decreased trauma and enhanced patient outcomes. The adoption of advanced imaging and catheter-based technologies further propels this movement, making such procedures more prevalent. This evolving landscape signals a rising demand for innovative treatment options that prioritize both efficacy and patient comfort within the neurosurgery sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Intracranial Aneurysm Market Size by Product Type & CAGR (2026-2033)

Market Overview
Aneurysm Therapeutic Devices
- Clips
- Coils
- Intravascular Devices
- Flow Diverter
Embolization Devices
- Occlusion Catheters
- Embolic Agent
Aspiration Devices
- Aspiration Catheter
- Clot Retrieval Device
Access Devices
- Micro Catheter
- Guidewire

Global Intracranial Aneurysm Market Size by Type & CAGR (2026-2033)

Market Overview
Saccular aneurysm
Fusiform aneurysm
Mycotic aneurysm

Global Intracranial Aneurysm Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Intracranial Aneurysm Market Size & CAGR (2026-2033)

North America (Product Type, Type, End-User)
- US
- Canada
Europe (Product Type, Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAUMEDIC AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Delta Surgical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Terumo (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt USA (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Medix Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evasc Neurovascular Enterprises ULC (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments